IRONWOOD PHARMACEUTICALS INC (IRWD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 150M 300M 450M FY24: 351.4M FY25: 296.2M FY24 FY25

Gross Profit Annual

0 150M 300M 450M FY19: 404.5M FY20: 386.4M FY19 FY20

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

0 35M 70M 105M FY24: 93.1M FY25: 98.5M FY24 FY25

Net Income Annual

0 9M 18M 27M FY24: 880K FY25: 24M FY24 FY25

Cost of Revenue Annual

0 9M 18M 27M FY19: 23.9M FY20: 3.1M FY19 FY20

Operating Cash Flow Annual

0 50M 100M 150M FY24: 103.5M FY25: 127M FY24 FY25

Free Cash Flow Annual

0 50M 100M 150M FY24: 103.4M FY25: 127M FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 60M 120M 180M FY24: 160.1M FY25: 163M FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.30 0.00 0.30 0.60 0.90 Q3 '24: -0.03 Q4 '24: -0.01 Q1 '25: -0.21 Q2 '25: -0.06 Q3 '25: 0.15 Q4 '25: 0.13 Q1 '26: 0.60 Q2 '26: 0.77 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.